
Exceptional event Life Sciences & Biotech (FABS)
2025 Life Sciences Panorama
Deadline for registration: Tuesday 21 October 2025 - 12:30 PM (UTC-4)
Register now !Next-Generation Collaborations and Deals in Life Sciences
13th Edition of the flagship annual event by FACCNE's Life Sciences, Biotechnology Forum
Join us for the 13th edition of the Life Sciences Panorama, our flagship annual event organized by the FABS, FACCNE's Life Sciences, Biotechnology Forum, dedicated to fostering innovation and knowledge exchange in the biopharma industry.
📆 Date: Wednesday, October 22, 2025
🕕 Time: 5:00 PM - 9:00 PM
📍 Location: Sanofi, 450 Water St, Cambridge (directions).
🎫 Registration: $50 for members, $70 for non-members.
Limited free tickets are available for Platinum members, please contact events@faccne.org.
About the Life Sciences Panorama:
FACCNE's Life Sciences Panorama is a premier forum bringing together industry leaders, investors, entrepreneurs, and innovators to explore the key forces shaping the future of healthcare. This year, we will dive deep into Next-Generation Collaborations and Deals in Life Sciences,
We will be exploring new funding models reshaping the path for pharma, biotech, and AI-driven health companies. We will also be sharing experiences on how early-stage ventures can turn research into lasting partnerships. Finally, we will explore how deal terms are evolving in today’s complex market.
This exclusive program will highlight the pivotal role that cross-border alliances, licensing, and M&A play in driving innovation and scaling biotech and medtech.
Prepare for an evening of thought-provoking discussions, expert panels, and unparalleled networking opportunities with stakeholders from both sides of the Atlantic, including the Business France NEXT Healthcare 2025 Delegation.
What to Expect:
- Host Welcome Address:
Presented by: Srini Rao - R&D US Country Lead, Global Head, Translational Models Research, Sanofi
- Opening Keynote: Funding Models for Biomedical Innovation
Building on his influential 2021 talk New Funding Models for Biomedical Innovation, Andrew Lo will deliver an updated perspective tailored for biotech founders and non-finance specialists. He will explore emerging and alternative funding models, how investor behavior is shifting and what it means for early-stage companies, and share insights from his latest research at MIT CSAIL, with a focus on AI-driven innovation.
Presented by: Dr. Andrew Lo - Charles E. and Susan T. Harris Professor, Director of the Laboratory for Financial Engineering, MIT Sloan School of Management
- Panel 1: Early-Stage Companies, Big Partnerships: Clever Strategies for Life Sciences Collaborations
Designed for research-driven startups, this panel will examine how early-stage ventures can leverage partnerships to accelerate growth. Topics include entry points and collaboration models across biotech, pharma, medtech, and digital health, structuring early-stage partnerships and building realistic roadmaps and innovative practices for alliance management, deal-making, and scaling long-term relationships.
- 🎤 Dr. Karen Chandross - Head of North America R&D External Innovation, Sanofi
- 🎤 Nelson Azoulay - SVP, Strategy and Business Development, Flagship Pioneering
- 🎤 Kevin Alessandri - Co-founder, CTO & US VP, TreeFrog Therapeutics
- 🎤 Heidi Sprang - Global BioPharma Executive
- Moderated by: Dr. Gigi Shafai, FABS Co-Chair
- Panel 2: Evolving Deal Terms for Life Science M&A
As consolidation accelerates and new players reshape the global market, deal-making is undergoing rapid change. This discussion will focus on emerging deal structures in today’s climate, the impact of macro trends on funding, M&A, and partnerships, and strategic advice for preparing for new market realities.
- 🎤 Dr. Anne Altmeyer - Former CEO, TigaTx; Board Member, Corbus
- 🎤 Julian Temple - Managing Director, Healthcare Group, Lazard.
- Moderated by: Jim Shanahan, FABS Co-Founder
- Closing Keynote
Key takeaways and forward-looking insights on market dynamics, creative deal structures, and what lies ahead for life sciences transactions.
Presented by: Dr. Arda Ural - Americas Life Sciences Leader, EY
- Cocktail & Networking Reception
Light networking refreshments will be served.
This event is made possible with the generous support of our sponsors: Sanofi, Ipsen, EY, Business France and Veridian Immigration.
This event is expected to sell out. We highly recommend you register your interest now to receive priority updates and secure your place.
Tickets for this event are transferable but not refundable, 48 hours before the event. FACCNE Members enjoy discounted prices. Become a member now and immediately save on your ticket(s)!
Unless otherwise communicated to our team prior to the event, attendees of this in-person event acknowledge that their photographs may be used on FACCNE’s social media channels and website.
Speaker(s)
Thank you for supporting this event!
🔗 Explore past editions:
2024 Life Sciences Panorama: Practical AI in Biopharma: Current and Future Directions
2023 Life Sciences Panorama: Spotlight on the French Health Ecosystem & Innovation
2022 Life Sciences Panorama: Health Innovation & Funding in the New Market Landscape
Event Location
